Acyclovir and Trikafta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Acyclovir (acyclovir) and Trikafta (elexacaftor, ivacaftor, tezacaftor; ivacaftor). Common drug interactions include decreased appetite among females and abdominal pain upper among males.

The phase IV clinical study analyzes what interactions people have when they take Acyclovir and Trikafta. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Acyclovir?

Acyclovir has active ingredients of acyclovir. It is often used in herpes simplex. eHealthMe is studying from 54,961 Acyclovir users. Check the latest studies of Acyclovir.

What is Trikafta?

Trikafta has active ingredients of elexacaftor, ivacaftor, tezacaftor; ivacaftor. eHealthMe is studying from 11,852 Trikafta users. Check the latest studies of Trikafta.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 22, 2026

17 people who take Acyclovir and Trikafta together, and have interactions are studied.

Acyclovir and Trikafta drug interactions.

What are the common drug interactions of Acyclovir and Trikafta, by gender? *:

female:

  1. Decreased appetite
  2. Pain
  3. Blood sodium decreased
  4. Contusion (a type of hematoma of tissue in which capillaries)
  5. Dehydration (dryness resulting from the removal of water)
  6. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  7. Overdose
  8. Pyrexia (fever)
  9. Spinal fracture (fracture in one of vertebrae)
  10. Stress fracture (fracture of a bone caused by repeated (rather than sudden) mechanical stress)

male:

  1. Abdominal pain upper

What are the common drug interactions of Acyclovir and Trikafta, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Asthenia (weakness)
  2. Contusion (a type of hematoma of tissue in which capillaries)
  3. Cough
  4. Decreased appetite
  5. Dizziness
  6. Fatigue (feeling of tiredness)
  7. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  8. Hepatic enzyme increased
  9. Hepatic failure (liver failure)
  10. Irritability

30-39:

  1. Depression
  2. Haemorrhagic ovarian cyst (bleeding ovarian cyst)
  3. Hypoglycaemia (deficiency of glucose in the bloodstream)
  4. Loss of consciousness
  5. Nausea (feeling of having an urge to vomit)
  6. Premature menopause
  7. Pruritus (severe itching of the skin)
  8. Rash pruritic (redness with itching)
  9. Weight increased
  10. Anxiety

40-49:

n/a

50-59:

  1. Abdominal pain upper
  2. Acute respiratory failure
  3. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  4. Infection
  5. Rehabilitation therapy

60+:

n/a

What are the existing conditions these people have? *

  1. Cystic Fibrosis (disease of the secretary glands): 14 people, 82.35%
  2. Cystic Fibrosis Lung (fibrosis with cyst in the lung): 4 people, 23.53%
  3. Broken Bone: 3 people, 17.65%
  4. Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 1 person, 5.88%
  5. Bacterial Infection: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Acyclovir and Trikafta?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Acyclovir and Trikafta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Acyclovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Trikafta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Acyclovir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Trikafta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on acyclovir and elexacaftor, ivacaftor, tezacaftor; ivacaftor (the active ingredients of Acyclovir and Trikafta, respectively), and Acyclovir and Trikafta (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: